chr2-151604849-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001164507.2(NEB):​c.12770G>A​(p.Arg4257His) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R4257C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 8)
Exomes 𝑓: 0.00043 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NEB
NM_001164507.2 missense

Scores

3
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 3.25

Publications

3 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009276062).
BP6
Variant 2-151604849-C-T is Benign according to our data. Variant chr2-151604849-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 509194. Variant chr2-151604849-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 509194. Variant chr2-151604849-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 509194. Variant chr2-151604849-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 509194. Variant chr2-151604849-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 509194. Variant chr2-151604849-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 509194. Variant chr2-151604849-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 509194.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.12770G>A p.Arg4257His missense_variant Exon 85 of 182 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.12770G>A p.Arg4257His missense_variant Exon 85 of 182 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.12770G>A p.Arg4257His missense_variant Exon 85 of 182 5 NM_001164508.2 ENSP00000380505.3 P20929-2
NEBENST00000427231.7 linkc.12770G>A p.Arg4257His missense_variant Exon 85 of 182 5 NM_001164507.2 ENSP00000416578.2 P20929-3
NEBENST00000409198.5 linkc.11601+4960G>A intron_variant Intron 78 of 149 5 ENSP00000386259.1 P20929-4

Frequencies

GnomAD3 genomes
AF:
0.00277
AC:
170
AN:
61412
Hom.:
1
Cov.:
8
show subpopulations
Gnomad AFR
AF:
0.0123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00280
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00714
Gnomad NFE
AF:
0.0000582
Gnomad OTH
AF:
0.00407
GnomAD2 exomes
AF:
0.00147
AC:
74
AN:
50432
AF XY:
0.00102
show subpopulations
Gnomad AFR exome
AF:
0.0132
Gnomad AMR exome
AF:
0.000445
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000140
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000101
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000433
AC:
192
AN:
443338
Hom.:
0
Cov.:
5
AF XY:
0.000347
AC XY:
81
AN XY:
233412
show subpopulations
African (AFR)
AF:
0.0129
AC:
131
AN:
10194
American (AMR)
AF:
0.000738
AC:
13
AN:
17622
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11584
East Asian (EAS)
AF:
0.0000452
AC:
1
AN:
22112
South Asian (SAS)
AF:
0.0000917
AC:
4
AN:
43638
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22574
Middle Eastern (MID)
AF:
0.000608
AC:
1
AN:
1644
European-Non Finnish (NFE)
AF:
0.0000515
AC:
15
AN:
291428
Other (OTH)
AF:
0.00120
AC:
27
AN:
22542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00277
AC:
170
AN:
61474
Hom.:
1
Cov.:
8
AF XY:
0.00244
AC XY:
70
AN XY:
28658
show subpopulations
African (AFR)
AF:
0.0123
AC:
152
AN:
12326
American (AMR)
AF:
0.00279
AC:
13
AN:
4662
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1704
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1886
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1480
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3844
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
134
European-Non Finnish (NFE)
AF:
0.0000582
AC:
2
AN:
34368
Other (OTH)
AF:
0.00402
AC:
3
AN:
746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00104
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Nemaline myopathy 2 Uncertain:1Benign:1
Nov 04, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant occurs in a region of NEB (Exons 82-105) consisting of three highly homologous 8-exon repeat units (exons 82-89, exons 90-97, exons 98-105). Sequence variants in this region can be detected, but this assay cannot determine which of the three repeat units is affected, and zygosity is often ambiguous. All variants in this region are reported relative to the exon 82-89 repeat. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with NEB-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Nov 11, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
Jun 23, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.092
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
24
DANN
Benign
0.86
DEOGEN2
Benign
0.029
.;T;.;.;.
Eigen
Benign
0.010
Eigen_PC
Benign
-0.00082
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.95
D;D;D;.;.
MetaRNN
Benign
0.0093
T;T;T;T;T
MetaSVM
Benign
-0.80
T
PhyloP100
3.3
PROVEAN
Benign
-1.1
N;.;N;.;.
REVEL
Benign
0.12
Sift
Benign
0.055
T;.;T;.;.
Sift4G
Uncertain
0.0030
D;D;D;D;D
Vest4
0.36
MutPred
0.50
Loss of MoRF binding (P = 0.0232);Loss of MoRF binding (P = 0.0232);Loss of MoRF binding (P = 0.0232);Loss of MoRF binding (P = 0.0232);Loss of MoRF binding (P = 0.0232);
MVP
0.69
MPC
0.34
ClinPred
0.043
T
GERP RS
3.2
gMVP
0.0023
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs576918934; hg19: chr2-152461363; API